Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A truncated six transmembrane splice variant MOR-1G enhances expression of the full-length seven transmembrane mu opioid receptor through heterodimerization

Tiffany Zhang, Jin Xu and Ying-Xian Pan
Molecular Pharmacology July 28, 2020, mol.120.119453; DOI: https://doi.org/10.1124/mol.120.119453
Tiffany Zhang
Memorial Sloan-Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Xu
Memorial Sloan-Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying-Xian Pan
Memorial Sloan-Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

The mu opioid receptor gene, OPRM1, undergoes extensive alternative splicing to generate an array of splice variants. One group of splice variants exclude the first transmembrane (TM) domain and contain six TM domains. These 6TM variants are essential for the action of a novel class of analgesic drugs, including 3-iodobenzoyl-6β-naltrexamide (IBNtxA), which is potent against a spectrum of pain models without exhibiting the adverse side effects of traditional opiates. The 6TM variants are also involved in analgesic action through other drug classes, including delta and kappa opioids, and α2-adrenergic drugs. Of the five 6TM variants in mouse, mMOR-1G is abundant and conserved from rodent to human. In the present study, we demonstrate a new function of mMOR-1G in enhancing expression of the full-length 7TM mu opioid receptor, mMOR-1. When co-expressed with mMOR-1 in a Tet-Off inducible Chinese Hamster Ovary cell line, mMOR-1G has no effect on mMOR-1 mRNA expression, but greatly increases mMOR-1 protein expression in a dose-dependent manner, determined by opioid receptor binding and [35S]GTPγS binding. Subcellular fractionation analysis using OptiPrep density gradient centrifugation shows an increase of functional mMOR-1 receptor in plasma membrane-enriched fractions. Using a co-immunoprecipitation approach, we further demonstrate that mMOR-1G physically associates with mMOR-1 starting at the endoplasmic reticulum, suggesting a chaperone-like function. These data provide a molecular mechanism for how mMOR-1G regulates expression and function of the full-length 7TM mu opioid receptor.

SIGNIFICANCE STATEMENT The current study establishes a novel function of mMOR-1G, a truncated splice variant with six transmembrane domains (TM) of the mouse mu opioid receptor gene, in enhancing expression of the full-length 7TM mMOR-1 through a chaperone-like function.

  • Antibodies
  • Chaperones
  • Drug abuse
  • G protein-coupled receptors (GPCRs)
  • Immunoprecipitation
  • Opioid receptors
  • Pain
  • Protein-protein interactions
  • Receptor structure
  • Receptor trafficking
  • The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 99 (2)
Molecular Pharmacology
Vol. 99, Issue 2
1 Feb 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A truncated six transmembrane splice variant MOR-1G enhances expression of the full-length seven transmembrane mu opioid receptor through heterodimerization
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A truncated six transmembrane splice variant MOR-1G enhances expression of the full-length seven transmembrane mu opioid receptor through heterodimerization

Tiffany Zhang, Jin Xu and Ying-Xian Pan
Molecular Pharmacology July 28, 2020, mol.120.119453; DOI: https://doi.org/10.1124/mol.120.119453

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

A truncated six transmembrane splice variant MOR-1G enhances expression of the full-length seven transmembrane mu opioid receptor through heterodimerization

Tiffany Zhang, Jin Xu and Ying-Xian Pan
Molecular Pharmacology July 28, 2020, mol.120.119453; DOI: https://doi.org/10.1124/mol.120.119453
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics